1.79 USD
+0.07 (+4.07%)
We assign a fundamental rating of 2 out of 10 to CSTE. CSTE was compared to 42 industry peers in the Building Products industry. While CSTE seems to be doing ok healthwise, there are quite some concerns on its profitability. CSTE does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
CSTE had negative earnings in the past year.
In the past year CSTE has reported a negative cash flow from operations.
In multiple years CSTE reported negative net income over the last 5 years.
Of the past 5 years CSTE 4 years had a positive operating cash flow.
1.2 Ratios
CSTE has a worse Return On Assets (-13.97%) than 80.95% of its industry peers.
CSTE's Return On Equity of -30.04% is on the low side compared to the rest of the industry. CSTE is outperformed by 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.97% | ||
| ROE | -30.04% | ||
| ROIC | N/A |
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CSTE has a Gross Margin of 19.38%. This is in the lower half of the industry: CSTE underperforms 73.81% of its industry peers.
CSTE's Gross Margin has declined in the last couple of years.
CSTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.38% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
2. Health
2.1 Basic Checks
CSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CSTE remains at a similar level compared to 1 year ago.
CSTE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CSTE has an improved debt to assets ratio.
2.2 Solvency
CSTE has an Altman-Z score of 1.32. This is a bad value and indicates that CSTE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.32, CSTE is doing worse than 92.86% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that CSTE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.00, CSTE belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.32 |
ROIC/WACCN/A
WACC8.42%
2.3 Liquidity
CSTE has a Current Ratio of 2.07. This indicates that CSTE is financially healthy and has no problem in meeting its short term obligations.
CSTE's Current ratio of 2.07 is fine compared to the rest of the industry. CSTE outperforms 64.29% of its industry peers.
CSTE has a Quick Ratio of 1.36. This is a normal value and indicates that CSTE is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.36, CSTE is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.36 |
3. Growth
3.1 Past
The earnings per share for CSTE have decreased strongly by -73.42% in the last year.
CSTE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.45%.
Measured over the past years, CSTE shows a decrease in Revenue. The Revenue has been decreasing by -4.09% on average per year.
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-15.45%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
3.2 Future
Based on estimates for the next years, CSTE will show a small growth in Earnings Per Share. The EPS will grow by 3.55% on average per year.
Based on estimates for the next years, CSTE will show a decrease in Revenue. The Revenue will decrease by -2.34% on average per year.
EPS Next Y-66.05%
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
EPS Next 5YN/A
Revenue Next Year-10.85%
Revenue Next 2Y-4.83%
Revenue Next 3Y-2.34%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CSTE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CSTE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
5. Dividend
5.1 Amount
CSTE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:CSTE (12/19/2025, 8:00:00 PM)
1.79
+0.07 (+4.07%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners27.96%
Inst Owner Change-9.11%
Ins Owners1.65%
Ins Owner ChangeN/A
Market Cap61.88M
Revenue(TTM)400.66M
Net Income(TTM)-70.09M
Analysts82.86
Price Target4.08 (127.93%)
Short Float %1.27%
Short Ratio0.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.48%
Min EPS beat(2)-79.74%
Max EPS beat(2)-35.23%
EPS beat(4)1
Avg EPS beat(4)-38.25%
Min EPS beat(4)-79.74%
Max EPS beat(4)11.15%
EPS beat(8)3
Avg EPS beat(8)-28.89%
EPS beat(12)3
Avg EPS beat(12)-233.01%
EPS beat(16)4
Avg EPS beat(16)-183.76%
Revenue beat(2)1
Avg Revenue beat(2)-2.34%
Min Revenue beat(2)-7.26%
Max Revenue beat(2)2.57%
Revenue beat(4)2
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-7.26%
Max Revenue beat(4)2.57%
Revenue beat(8)3
Avg Revenue beat(8)-4.15%
Revenue beat(12)3
Avg Revenue beat(12)-5.84%
Revenue beat(16)4
Avg Revenue beat(16)-4.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.71%
EPS NY rev (1m)-16.67%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)1.59%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.15 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.27 | ||
| P/tB | 0.27 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.37
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS11.59
BVpS6.75
TBVpS6.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.97% | ||
| ROE | -30.04% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 19.38% | ||
| FCFM | N/A |
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
F-Score2
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 71.22% | ||
| Cap/Sales | 2.6% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.07 | ||
| Quick Ratio | 1.36 | ||
| Altman-Z | 1.32 |
F-Score2
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)60.64%
Cap/Sales(3y)2.3%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-66.05%
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.45%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
Revenue Next Year-10.85%
Revenue Next 2Y-4.83%
Revenue Next 3Y-2.34%
Revenue Next 5YN/A
EBIT growth 1Y-69.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.38%
EBIT Next 3Y24.13%
EBIT Next 5YN/A
FCF growth 1Y-201.95%
FCF growth 3YN/A
FCF growth 5Y-18.43%
OCF growth 1Y-157.02%
OCF growth 3Y15.48%
OCF growth 5Y-17.42%
CAESARSTONE LTD / CSTE FAQ
What is the ChartMill fundamental rating of CAESARSTONE LTD (CSTE) stock?
ChartMill assigns a fundamental rating of 2 / 10 to CSTE.
What is the valuation status for CSTE stock?
ChartMill assigns a valuation rating of 0 / 10 to CAESARSTONE LTD (CSTE). This can be considered as Overvalued.
What is the profitability of CSTE stock?
CAESARSTONE LTD (CSTE) has a profitability rating of 1 / 10.
What is the expected EPS growth for CAESARSTONE LTD (CSTE) stock?
The Earnings per Share (EPS) of CAESARSTONE LTD (CSTE) is expected to decline by -66.05% in the next year.
Can you provide the dividend sustainability for CSTE stock?
The dividend rating of CAESARSTONE LTD (CSTE) is 0 / 10 and the dividend payout ratio is 0%.